BSE 200 News and Updates

Name: Latest research reports of Hindalco Industries Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Hindalco Industries Ltd.
Rating: 3
Author: Geojit BNP Paribas

Keep track of all breaking news on BSE 200 from all sources in a single place.

Load latest

Kotak Mahindra Bank Ltd.

03 Sep 2025

2150.20

2.37%

Kotak Mahindra Bank Back In The Race For IDBI Bank

NDTV Profit

The government is expected to invite final bids for IDBI Bank by the next quarter.

Kotak Mahindra Bank Ltd. is trading above all available SMAs

Apollo Hospitals Enterprise Ltd.

03 Sep 2025

7640.50

2.56%

Delhi-NCR sees spike in dengue, other infectious diseases post-monsoon

Business Standard

Dr Jatin Ahuja, Infectious Diseases Specialist at Apollo Hospital, said the rise is largely linked to seasonal changes driven by monsoon-related conditions like stagnant water and increased humidity

Apollo Hospitals Enterprise Ltd. is trading below its 30 day SMA of 7736.0

UPL Ltd.

03 Sep 2025

678.00

0.59%

UPL Shares In Focus As Company Eyes Value Unlocking Through Key Restructuring Exercise

NDTV Profit

Decco is recognised globally for its innovative technologies that extend the safety, quality, and shelf life of fresh produce.

UPL Ltd.'s price crossed above 100Day SMA today

Hindalco Industries Ltd.

03 Sep 2025

777.25

-0.40%

HINDALCO INDUSTRIES LIMITED

Hold: Hindalco Industries Ltd.

Target

Geojit BNP Paribas

Despite a tough economic environment, Novelis delivered steady results. Also, to a cost reduction programme. However, Novelis faces tariff exposure on imports and is actively pursuing mitigation measures. Considering these factors, we retain our HOLD...

Hindalco Industries Ltd. has gained 29.55% in the last 6 Months

Zydus Lifesciences Ltd.

03 Sep 2025

988.05

-0.03%

ZYDUS LIFESCIENCES LIMITED

Buy: Zydus Lifesciences Ltd.

Target

Geojit BNP Paribas

*over or under performance to benchmark index Zydus Lifesciences Ltd (Zydus) is one of India's leading, vertically integrated pharmaceutical companies. It operates across the value chain, from manufacturing finished dosages to active pharmaceutical ingredients, as well as animal healthcare and wellness products. Zydus' revenue increased 5.9% YoY to Rs. 6,574cr in Q1FY26 driven by 6.5% YoY...

Zydus Lifesciences Ltd. is trading above its 200 day SMA of 949.4

ICICI Bank Ltd.

03 Sep 2025

1363.50

-0.12%

Well placed to allay growth/asset quality challenges

Buy: ICICI Bank Ltd.

Target

Emkay

ICICIB reported some moderation in credit growth at ~12% YoY in 1Q, mainly due to slower growth in retail loans (incl mortgages and unsecured loans) and demand remaining slack in the corporate portfolio.

Number of FII/FPI investors increased from 2439 to 2512 in Jun 2025 qtr.

Tech Mahindra Ltd.

03 Sep 2025

1436.00

2.53%

Axis Punch:Tech Mahindra

Buy: Tech Mahindra Ltd.

Target

Axis Direct

At current levels, the stock is attractively valued. We recommend a BUY rating with a TP of Rs 1,660/share, implying an upside of 10% from CMP.

Number of FII/FPI investors increased from 1095 to 1103 in Jun 2025 qtr.

Astral Ltd.

03 Sep 2025

1385.40

0.13%

Axis Punch:Astral

Buy: Astral Ltd.

Target

Axis Direct

We recommend a BUY on the stock with a target price of Rs 1,570/share, implying an upside of 10% from the CMP.

Astral Ltd. is trading below all available SMAs

UPL Ltd.

03 Sep 2025

678.00

0.59%

Stock Flash

Accumulate: UPL Ltd.

Target

Deven Choksey

UPL Limited has announced an internal realignment involving the integration of its Post Harvest Business (Decco) with the Advanta seed business.

UPL Ltd. is trading below its 30 day SMA of 694.6

IndusInd Bank Ltd.

02 Sep 2025

738.45

-1.20%

IndusInd Bank appoints Pragati Gondhalekar as head of internal audit

Business Line

Pragati Gondhalekar's appointment comes amid a leadership rejig at the private bank, which faced material losses due to accounting discrepancies in derivatives portfolio

IndusInd Bank Ltd. is trading below all available SMAs

Is BSE 200 worth buying?

5 Votes:

Buy 60.0%

Hold 40.0%

BSE 200 PB	4.2
BSE 200 PE	23.6
BSE 200 DIV	1.2
BSE 200 EPS	479.2